BioLamina is a biotechnology company offering cell culture matrices for primary cells. It provides a portfolio of recombinant laminin proteins for a variety of applications, including expansion of pluripotent cell as well as differentiation and maintenance of specialized cell types. Its chemically defined and xeno-free laminin cell culture matrices allow customers to imitate the natural cell-matrix interaction in vitro.